Flagship explainer
What drives Silo Pharma, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$4.2M | FY2025 |
| |
| Income before tax | −$4.2M | FY2025 |
|
| Operating income | −$4.3M | FY2025 |
|
| $72102 | FY2025 |
| |
| Ending assets | $7.6M | FY2025 |
|
| Beginning assets | $7.4M | FY2024 |
|
| $6.3M | FY2025 |
| |
| $5M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001213900-26-035576